DA
CELU icon

DSC Advisors’s Celularity CELU Stock Holding History

DSC Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,000
Closed -$550K – 83
2020
Q4 		$550K Buy
+5,000
New +$531K 0.45% 29

Other funds holding CELU

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

DSC Advisors's CELU Position: Q1 2021 in Review

DSC Advisors sold out of Celularity (CELU) in Q1 2021, closing a stake of 5,000 shares — an estimated $550K sold.

DSC Advisors first reported a position in CELU in Q4 2020 and held it in 1 quarter. The position peaked at $550K in Q4 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

  • DSC Advisors reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
  • DSC Advisors sold 5,000 Celularity shares in Q1 2021, an estimated $550K.
  • DSC Advisors first reported a position in Celularity in Q4 2020 and held it in 1 quarter.
  • DSC Advisors's Celularity position peaked at $550K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on DSC Advisors's 13F filing for Q1 2021, filed 14 May 2021.